Life sciences · Journal article
Acs Applied Materials & Interfaces · October 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Photothermal therapy (PTT) is a promising cancer treatment modality, but its evaluation remains limited by the lack of physiologically relevant and quantitatively controlled in vitro platforms. Here, we present a droplet-based microfluidic platform that enables single-spheroid formation, programmable nanoparticle delivery, and in situ laser irradiation with real-time thermal monitoring. The platform enables temperature multiplexing within a single experiment, allowing construction of single-spheroid dose–response relationships and the definition of a temperature-based inhibitory metric (IT50). This provides a direct and physically meaningful quantification of photothermal efficacy. In parallel, a label-free, spheroid morphology-based machine learning approach predicts treatment response across cell types, nanoparticle incubation conditions, and therapeutic regimes while preserving intrinsic single-spheroid variability. Despite a limited dataset size and biological heterogeneity, the system achieves robust and reproducible predictive performance. Overall, this work establishes a scalable and versatile microfluidic framework for quantitative photothermal nanotherapy screening, integrating controlled thermal dosing, 3D tumor models, and morphological data-driven analysis within a single-spheroid platform.